Scientia Professor Helen Christensen has received the James Cook Medal, with academics from Medicine & Health, Science and UNSW Canberra recognised with awards for research and scholarly excellence.
Projects that will improve hypertension treatments and use AI to personalise mental health treatments have received NHMRC funding.
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
People who ruminated and worried excessively were helped by an online course, a randomised controlled trial found.
Promising results in a trial of ketamine for severe depression could lead to treatment becoming more affordable.
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Australia needs to be careful when implementing MDMA and psilocybin therapy, says UNSW researcher Professor Colleen Loo.
The risk of repeat self-harm in young people is highest in the first month after an initial self-harm hospital presentation.
Phobias are when fears become excessive and interrupt daily life. A new review shows one longer session of exposure is as effective and more time-efficient than shorter sessions.
Machine learning algorithms could be more accurate and reliable than conventional methods of predicting suicide risk.